Header Logo

Connection

Elizabeth Berry-Kravis to Nootropic Agents

Back to Details
This is a "connection" page, showing publications Elizabeth Berry-Kravis has written about Nootropic Agents.
Elizabeth Berry-Kravis
Connection Strength
0.275
Nootropic Agents
  1. Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS). PLoS One. 2020; 15(2):e0225191.
    View in: PubMed
    Score: 0.176
  2. Fragile X syndrome and targeted treatment trials. Results Probl Cell Differ. 2012; 54:297-335.
    View in: PubMed
    Score: 0.100
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.